» Articles » PMID: 38028642

HAT Therapy for Sepsis: A Review of the Therapeutic Rationale and Current Clinical Evaluation Status

Overview
Journal J Intensive Med
Specialty Critical Care
Date 2023 Nov 29
PMID 38028642
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin C-based cluster therapy, which involves the combined application of hydrocortisone, vitamin C, and thiamine (HAT), is a recently proposed new treatment option for sepsis on top of conventional treatment. This therapy has a strong theoretical basis, but its clinical efficacy remains inconclusive. This review summarizes the rationale for HAT therapy for sepsis and describes the evaluation of its efficacy in clinical observational studies and randomized controlled trials, with the aim of providing a reference for the future clinical practice application of HAT therapy in sepsis.

References
1.
Hudson E, Collie J, Fujii T, Luethi N, Udy A, Doherty S . Pharmacokinetic data support 6-hourly dosing of intravenous vitamin C to critically ill patients with septic shock. Crit Care Resusc. 2019; 21(4):236-42. View

2.
Fujii T, Fowler R, Vincent J . Vitamin C and thiamine for sepsis: time to go back to fundamental principles. Intensive Care Med. 2020; 46(11):2061-2063. DOI: 10.1007/s00134-020-06242-9. View

3.
Moskowitz A, Andersen L, Huang D, Berg K, Grossestreuer A, Marik P . Ascorbic acid, corticosteroids, and thiamine in sepsis: a review of the biologic rationale and the present state of clinical evaluation. Crit Care. 2018; 22(1):283. PMC: 6206928. DOI: 10.1186/s13054-018-2217-4. View

4.
Ge Z, Huang J, Liu Y, Xiang J, Gao Y, Walline J . Thiamine combined with vitamin C in sepsis or septic shock: a systematic review and meta-analysis. Eur J Emerg Med. 2021; 28(3):189-195. DOI: 10.1097/MEJ.0000000000000812. View

5.
Holford P, Carr A, Jovic T, Ali S, Whitaker I, Marik P . Vitamin C-An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19. Nutrients. 2020; 12(12). PMC: 7762433. DOI: 10.3390/nu12123760. View